Navigation Links
China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
Date:4/21/2008

GUANGZHOU, China, April 21 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of ethical and over-the-counter drugs, traditional Chinese medicines (TCM), nutritional and dietary supplements, medical devices, and medical formulations in the PRC, today announced that the Company was selected by the Guangzhou Technology Bureau to represent Guangzhou city's biotechnology industry at the 15th Annual BIO International Convention, hosted by the Biotechnology Industry Organization. The convention will be held from June 17th to June 20th 2008 at San Diego Convention Center in San Diego, California.

China Medicine Corporation will present the development of its proprietary drugs -- Yutian Capsule, a class II TCM new drug, together with KY Polysaccharides and Aflatoxin Detoxifyzyme at the conference.

Yutian Capsule and KY Polysaccharide have been developed for the treatment of lung disease and lung cancer. Both these products have been approved by the Guangzhou Technology Bureau. The Company has successfully shown the chemical structure as well as the molecular weight of the compounds in these two drugs. This is a breakthrough for Traditional Chinese Medicine ("TCM") research as TCM has entered a new era of molecular level research.

In addition, China Medicine will also present its Aflatoxin-Detoxifizyme ("ADTZ") project, which has been accepted by the High-Tech National Natural Science Foundation of China as a part of the China's National "863 Plan." ADTZ is an enzyme that can eliminate aflatoxin from food and animal feed. The Company will launch its trial sales in 2008.

"This is an important event for China Medicine as we will be representing the entire biotechnology industry in Guangzhou city to participate in this conference. Guangzhou Technology bureau intends to leverage this conference as an opportunity to showcase and globalize the city's
'/>"/>

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...stCall/ -- Universal Health,Realty Income Trust (...ded their,Board of Trustees with the appointment ...rsal Health Services, Inc. (UHS). Mr. Miller brin...lthcare leadership roles. He has,served as UHS, ...e Division,since 2007 and prior to that, served a...
(Date:12/4/2008)...ant gene could ease sickle-cell disease and thalas...4, 2008 -- Researchers at Children,s Hospital Bost...ancer Institute have identified a way to get red b...y made only before birth or by young infants. This...nd beta-thalassemia -- life-threatening inherited ...
(Date:12/4/2008)...en Joffe, Craig Joffe, and,Alan Buckey today file...,Securities and Exchange Commission. The group p...4% of LCA-Vision, Inc. (Nasdaq: LCAV ), which,o...ction centers in 33 states,in the United States. ...CEO of,LCAV. Craig Joffe is the former Chief Ope...
(Date:12/4/2008)..." , , WASHINGTON, Dec. 4 /PRNewswire-USNews...into question the safety of the Centers for Diseas...dministering multiple vaccines concurrently. , ...sorder Patients, published last week in PLOS One ...Hopkins Kennedy Krieger Institute and Massachusett...
Breaking Medicine News(10 mins):Health News:Turning back the Clock in Inherited Anemias 2Health News:Turning back the Clock in Inherited Anemias 3Health News:Turning back the Clock in Inherited Anemias 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 3Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 5Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 6Health News:Researchers & Department of Defense Question Multiple Vaccine Administration 2
...vitamin is a must in the medicine chest of a pregn...ic acid could lead to serious birth defects// in t... the risk of stroke and heart disease. Now, there ...a Dutch study has shown. Folic acid may actually ...
...hters and no sons, may have a greater risk of gett...A team of Israeli researchers compared families of... and found that having more daughters and risk of ... The Journal of the National Cancer Institute stu...
...ple the number of influenza cases over the last fo...da, according to statistics released by the Public...uns from October to late March or early April and ...onitors likely outbreaks during this time. Sympto...
...ed on the data put together in health maps, show t...irst 10 unhealthiest places.// Valley areas have ...rchers suggest inner-city areas will soon overtake...wing obesity crisis in South Wales has become more...
Other Medicine News:Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2Health News:Lifestyles Cause Concern To Welsh Health Officials 2
(Date:12/3/2008)...SAN DIEGO, Dec. 3 Vical ... exclusive, binding letter of intent with EIP,Ecz...rketing of the company,s,Allovectin-7(R) immunoth...ish,Republic of Northern Cyprus. EIP has agreed t...he territory and to pay Vical upfront and mileston...
(Date:12/2/2008)...CHICAGO, Dec. 3 Breast-... detection of cancers not found on mammograms or b...oday at the annual meeting of,the Radiological So...identify the most difficult to detect breast cance...achel F. Brem, M.D., professor of,radiology and d...
(Date:12/2/2008)...LENEXA, Kan., Dec. 2 IBT Laborator...l-research laboratory specializing in immunology a...two tests to evaluate the response of patients w...imary immunodeficiency disorder, chemotherapy drug...rugs to prevent rejection of a transplant. The com...
(Date:12/2/2008)...SKOKIE, Ill., Dec. 2 Horizon Thera... company, today announced that two pivotal,Phase ...ct candidate, HZT-501,met all primary endpoints....tion product containing ibuprofen and famotidine, ...n in the incidence of non-steroidal,anti-inflamma...
Breaking Medicine Technology:Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Hospitals still not smoke free 13512 1Hospitals still not smoke free 13512 2Smith 26 Nephew Introduces New Biologic to Speed Healing 13508 1Smith 26 Nephew Introduces New Biologic to Speed Healing 13508 2Smith 26 Nephew Introduces New Biologic to Speed Healing 13508 3Unique Line of Custom Made Orthotics for Sandals and Clogs Cater to Style Minded Foot Pain Sufferers 13504 1Unique Line of Custom Made Orthotics for Sandals and Clogs Cater to Style Minded Foot Pain Sufferers 13504 2Edwards Lifesciences Announces First Human Implants of Next Generation Transcatheter Heart Valve 3725 1Edwards Lifesciences Announces First Human Implants of Next Generation Transcatheter Heart Valve 3725 2Edwards Lifesciences Announces First Human Implants of Next Generation Transcatheter Heart Valve 3725 3
.... Contributing Editor , ,Celiac disease (CD) ... intestine that is triggered in genetically suscep...ining grains wheat, rye, barley, and possibly oats...vation of both a T-cell and B-cell immune response..., and crypt hyperplasia, and is self-perpetuating ...
...Francois Rossi Medical Hematology and Oncology CHU...n (CRP) is an acute-phase protein that has long be.... CRP measurement can complement a range of diagno...ment. However, as economic rationalization become...t is apparent that such areas of frequent laborato...
Other Medicine Technology:Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4
The Polaris-DX steerable diagnostic catheter is designed for comfort and ergonomic handling during mapping procedures.
...eter, combines an octapolar configuration with eig...use of only one catheter for simultaneous Parahisi.... The "two catheters in one" design enables insert...he disadvantages of using two catheters with the i...
Inquiry 5FR Soft HIS diagnostic catheters provide the electrophysiologist with a uniquely designed curve that allows for placement and recording in the HIS bundle. In addition, the soft tubing is des
...vailable in a wide range of models and configurati...and several curve and connector types. Each cathet...cations, using only the highest quality materials....wire-braiding and extrusion technologies results i...
Medicine Products: